Effectiveness of Hydrogen Rich Water on Antioxidant Status of Subjects with Potential Metabolic Syndrome—An Open Label Pilot Study

Metabolic syndrome is characterized by cardiometabolic risk factors that include obesity, insulin resistance, hypertension and dyslipidemia. Oxidative stress is known to play a major role in the pathogenesis of metabolic syndrome. The objective of this study was to examine the effectiveness of hydrogen rich water (1.5–2 L/day) in an open label, 8-week study on 20 subjects with potential metabolic syndrome. Hydrogen rich water was produced, by placing a metallic magnesium stick into drinking water (hydrogen concentration; 0.55–0.65 mM), by the following chemical reaction; Mg + 2H2O → Mg (OH)2 + H2. The consumption of hydrogen rich water for 8 weeks resulted in a 39% increase (p<0.05) in antioxidant enzyme superoxide dismutase (SOD) and a 43% decrease (p<0.05) in thiobarbituric acid reactive substances (TBARS) in urine. Further, subjects demonstrated an 8% increase in high density lipoprotein (HDL)-cholesterol and a 13% decrease in total cholesterol/HDL-cholesterol from baseline to week 4. There was no change in fasting glucose levels during the 8 week study. In conclusion, drinking hydrogen rich water represents a potentially novel therapeutic and preventive strategy for metabolic syndrome. The portable magnesium stick was a safe, easy and effective method of delivering hydrogen rich water for daily consumption by participants in the study.

[1]  S. Ohta,et al.  Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice , 2009, Cancer Chemotherapy and Pharmacology.

[2]  K. Nishimaki,et al.  Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. , 2008, Biochemical and biophysical research communications.

[3]  A. Ishigami,et al.  Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. , 2008, Biochemical and biophysical research communications.

[4]  A J Bauer,et al.  Hydrogen Inhalation Ameliorates Oxidative Stress in Transplantation Induced Intestinal Graft Injury , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  Duk-Hee Lee,et al.  Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. , 2008, JAMA.

[6]  T. Yoshikawa,et al.  Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. , 2008, Nutrition research.

[7]  Yasuo Katayama,et al.  Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals , 2007, Nature Medicine.

[8]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[9]  D. Jacobs,et al.  ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress? , 2004, Free radical research.

[10]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Mokdad,et al.  The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. , 2003, Diabetes.

[12]  F. Bach,et al.  Heme oxygenase-1: unleashing the protective properties of heme. , 2003, Trends in immunology.

[13]  J. Crapo,et al.  Superoxide dismutases in the lung and human lung diseases. , 2003, American journal of respiratory and critical care medicine.

[14]  Rana Noor,et al.  Superoxide dismutase--applications and relevance to human diseases. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[15]  D. Harrison,et al.  Extracellular superoxide dismutase and cardiovascular disease. , 2002, Cardiovascular research.

[16]  E. Schaefer,et al.  Diagnosis and management of lipoprotein abnormalities. , 2002, Nutrition in clinical care : an official publication of Tufts University.

[17]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[18]  J. Whitfield.  Gamma Glutamyl Transferase , 2001, Critical reviews in clinical laboratory sciences.

[19]  J. Feng,et al.  Nutraceutical interventions may delay aging and the age-related diseases , 2000, Experimental Gerontology.

[20]  M. Nazıroğlu,et al.  Protective effects of selenium, vitamin C and vitamin E against oxidative stress of cigarette smoke in rats , 1999, Cell biochemistry and function.

[21]  R. Dean,et al.  Biochemistry and pathology of radical-mediated protein oxidation. , 1997, The Biochemical journal.

[22]  S. Srinivasan,et al.  Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. , 1997, Atherosclerosis.

[23]  S. Loft,et al.  8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. , 1993, Journal of toxicology and environmental health.

[24]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[25]  B. Halliwell.  Reactive oxygen species in living systems: source, biochemistry, and role in human disease. , 1991, The American journal of medicine.

[26]  H. Marver,et al.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Nakao,et al.  ORAL ADMINISTRATION OF HYDROGEN WATER PREVENTS CHRONIC ALLOGRAFT NEPHROPATHY IN RAT RENAL TRANSPLANTATION , 2009 .

[28]  K. Yagi.  Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. , 1998, Methods in molecular biology.

[29]  H. Schwertner,et al.  Association of low serum concentration of bilirubin with increased risk of coronary artery disease. , 1994, Clinical chemistry.